Francisco Javier Redondo (Francisco Javier Redondo Calvo, Javier Redondo-Calvo, Francisco Javier Redondo-Calvo)

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 21

Top Topics

Coronavirus Disease

Top Venues

International journal of molecular sciences

Current oncology (Toronto, Ont.)

Materials (Basel, Switzerland)

This page only lists publications with an associated author ORCID identifier.

Publications

Pedro Villarejo Campos, Susana Sánchez García, Mariano Amo-Salas, Esther García Santos, Carlos López de la Manzanara, Ana Alberca, David Padilla-Valverde, Francisco Javier Redondo, Jesús Martín
Paclitaxel as HIPEC-Drug after Surgical Cytoreduction for Ovarian Peritoneal Metastases: A Randomized Phase III Clinical Trial (HIPECOVA). Current oncology (Toronto, Ont.) 31 (2) (2024)
Juan-Fernando Padín, Jose Manuel Perez-Ortiz, Francisco Javier Redondo
Aprotinin (I): Understanding the Role of Host Proteases in COVID-19 and the Importance of Pharmacologically Regulating Their Function. International journal of molecular sciences 25 (14) (2024)
Pedro Villarejo Campos, Susana Sánchez García, Mariano Amo-Salas, Esther García Santos, Carlos López de la Manzanara, Ana Alberca, David Padilla-Valverde, Francisco Javier Redondo, Jesús Martín
Paclitaxel as HIPEC-Drug after Surgical Cytoreduction for Ovarian Peritoneal Metastases: A Randomized Phase III Clinical Trial (HIPECOVA). Current oncology (Toronto, Ont.) 31 (2) (2024)
Juan-Fernando Padín, Jose Manuel Perez-Ortiz, Francisco Javier Redondo
Aprotinin (I): Understanding the Role of Host Proteases in COVID-19 and the Importance of Pharmacologically Regulating Their Function. International journal of molecular sciences 25 (14) (2024)
David Padilla-Valverde, Raquel Bodoque-Villar, Esther García-Santos, Susana Sanchez, Carmen Manzanares-Campillo, Marta Rodriguez, Lucia González, Alfonso Ambrós, Juana M Cano, Maria Padilla-Marcote, Francisco Javier Redondo, Jesus Martin, Leticia Serrano-Oviedo
Safety and Effectiveness of Perioperative Hyperthermic Intraperitoneal Chemotherapy with Gemcitabine in Patients with Resected Pancreatic Ductal Adenocarcinoma: Clinical Trial EudraCT 2016-004298-41. Cancers 16 (9) (2024)
Pedro Villarejo Campos, Susana Sánchez García, Mariano Amo-Salas, Esther García Santos, Carlos López de la Manzanara, Ana Alberca, David Padilla-Valverde, Francisco Javier Redondo, Jesús Martín
Paclitaxel as HIPEC-Drug after Surgical Cytoreduction for Ovarian Peritoneal Metastases: A Randomized Phase III Clinical Trial (HIPECOVA). Current oncology (Toronto, Ont.) 31 (2) (2024)
Pedro Villarejo Campos, Susana Sánchez García, Mariano Amo-Salas, Esther García Santos, Carlos López de la Manzanara, Ana Alberca, David Padilla-Valverde, Francisco Javier Redondo, Jesús Martín
Paclitaxel as HIPEC-Drug after Surgical Cytoreduction for Ovarian Peritoneal Metastases: A Randomized Phase III Clinical Trial (HIPECOVA). Current oncology (Toronto, Ont.) 31 (2) (2024)
Juan-Fernando Padín, Jose Manuel Perez-Ortiz, Francisco Javier Redondo
Aprotinin (I): Understanding the Role of Host Proteases in COVID-19 and the Importance of Pharmacologically Regulating Their Function. International journal of molecular sciences 25 (14) (2024)
Pedro Villarejo Campos, Susana Sánchez García, Mariano Amo-Salas, Esther García Santos, Carlos López de la Manzanara, Ana Alberca, David Padilla-Valverde, Francisco Javier Redondo, Jesús Martín
Paclitaxel as HIPEC-Drug after Surgical Cytoreduction for Ovarian Peritoneal Metastases: A Randomized Phase III Clinical Trial (HIPECOVA). Current oncology (Toronto, Ont.) 31 (2) (2024)
Juan-Fernando Padín, Jose Manuel Perez-Ortiz, Francisco Javier Redondo
Aprotinin (II): Inhalational Administration for the Treatment of COVID-19 and Other Viral Conditions. International journal of molecular sciences 25 (13) (2024)
Juan-Fernando Padín, Jose Manuel Perez-Ortiz, Francisco Javier Redondo
Aprotinin (II): Inhalational Administration for the Treatment of COVID-19 and Other Viral Conditions. International journal of molecular sciences 25 (13) (2024)
David Padilla-Valverde, Raquel Bodoque-Villar, Esther García-Santos, Susana Sanchez, Carmen Manzanares-Campillo, Marta Rodriguez, Lucia González, Alfonso Ambrós, Juana M Cano, Maria Padilla-Marcote, Francisco Javier Redondo, Jesus Martin, Leticia Serrano-Oviedo
Safety and Effectiveness of Perioperative Hyperthermic Intraperitoneal Chemotherapy with Gemcitabine in Patients with Resected Pancreatic Ductal Adenocarcinoma: Clinical Trial EudraCT 2016-004298-41. Cancers 16 (9) (2024)
María Del Prado Garrido, Ana Maria Borreguero, Maria Jesus Ramos, Manuel Carmona, Francisco Javier Redondo, Juan Francisco Rodriguez Romero
Crosslinked Bifunctional Particles for the Removal of Bilirubin in Hyperbilirubinemia Cases. Materials (Basel, Switzerland) 16 (8) (2023)
María Del Prado Garrido, Ana Maria Borreguero, Maria Jesus Ramos, Manuel Carmona, Francisco Javier Redondo, Juan Francisco Rodriguez Romero
Crosslinked Bifunctional Particles for the Removal of Bilirubin in Hyperbilirubinemia Cases. Materials (Basel, Switzerland) 16 (8) (2023)
José Avendaño-Ortiz, Francisco Javier Redondo, Roberto Lozano-Rodríguez, Verónica Terrón-Arcos, Marta Bergón-Gutiérrez, Concepción Rodríguez-Jiménez, Juan Francisco Rodriguez Romero, Rosa Del Campo, Luis Antonio Gómez, Natalia Bejarano-Ramírez, Jose Manuel Perez-Ortiz, Eduardo López-Collazo
Thiosulfinate-Enriched Allium sativum Extract Exhibits Differential Effects between Healthy and Sepsis Patients: The Implication of HIF-1α. International journal of molecular sciences 24 (7) (2023)
María Del Prado Garrido, Ana Maria Borreguero, Maria Jesus Ramos, Manuel Carmona, Francisco Javier Redondo, Juan Francisco Rodriguez Romero
Crosslinked Bifunctional Particles for the Removal of Bilirubin in Hyperbilirubinemia Cases. Materials (Basel, Switzerland) 16 (8) (2023)
Francisco Javier Redondo, Juan-Fernando Padín, Jose Ramon Muñoz-Rodriguez, Leticia Serrano-Oviedo, Pilar López-Juárez, María Lourdes Porras Leal, Francisco Javier González Gasca, Marta Rodríguez Martínez, Raúl Pérez Serrano, Abraham Sánchez Cadena, Natalia Bejarano-Ramírez, Constanza Muñoz Hornero, José Ramón Barberá Farré, Inmaculada Domínguez-Quesada, María A Sepúlveda Berrocal, María Dolores Villegas Fernández-Infantes, María Isabel Manrique Romo, Ángel Parra Comino, Jose Manuel Perez-Ortiz, Francisco Javier Gómez-Romero, null null
Aprotinin treatment against SARS-CoV-2: A randomized phase III study to evaluate the safety and efficacy of a pan-protease inhibitor for moderate COVID-19. European journal of clinical investigation 52 (6) (2022)
María Del Prado Garrido, Ana Maria Borreguero, Francisco Javier Redondo, David Padilla, Manuel Carmona, Maria Jesus Ramos, Juan Francisco Rodriguez Romero
Functionalization of Poly(styrene-co-methyl methacrylate) Particles for Selective Removal of Bilirubin. Materials (Basel, Switzerland) 15 (17) (2022)
Francisco Javier Redondo, Natalia Bejarano-Ramírez, Víctor Baladrón, Omar Montenegro, Luis Antonio Gómez, Rubén Velasco, Natalia Villasanti, Soledad Illescas, María Teresa Franco-Sereno, Ignacio Gracia, Juan Francisco Rodriguez Romero, José Ramón Muñoz-Rodríguez, Jose Manuel Perez-Ortiz
Black Garlic and Thiosulfinate-Enriched Extracts as Adjuvants to Ceftriaxone Treatment in a Rat Peritonitis Model of Sepsis. Biomedicines 10 (12) (2022)
Francisco Javier Redondo, Natalia Bejarano-Ramírez, Víctor Baladrón, Omar Montenegro, Luis Antonio Gómez, Rubén Velasco, Natalia Villasanti, Soledad Illescas, María Teresa Franco-Sereno, Ignacio Gracia, Juan Francisco Rodriguez Romero, José Ramón Muñoz-Rodríguez, Jose Manuel Perez-Ortiz
Black Garlic and Thiosulfinate-Enriched Extracts as Adjuvants to Ceftriaxone Treatment in a Rat Peritonitis Model of Sepsis. Biomedicines 10 (12) (2022)
Juan Luis Santiago, Jose Ramon Muñoz-Rodriguez, Miguel Angel de la Cruz-Morcillo, Clara Villar-Rodriguez, Lucia Gonzalez-Lopez, Carolina Aguado, Miriam Nuncia-Cantarero, Francisco Javier Redondo, Jose Manuel Perez-Ortiz, Eva Maria Galan-Moya
Characterization of Permeability Barrier Dysfunction in a Murine Model of Cutaneous Field Cancerization Following Chronic UV-B Irradiation: Implications for the Pathogenesis of Skin Cancer. Cancers 13 (16) (2021)